Patients' Choice Medical Clinic Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 501 Azalea Dr, Suite F, Waynesboro, MS 39367 Phone: 601-735-3737 |
Waynesboro Family Medicine & Obstetrics Family Medicine Medicare: Medicare Enrolled Practice Location: 951 Matthew Dr Ste A, Waynesboro, MS 39367 Phone: 601-735-2401 Fax: 601-735-5205 |
Arthur E Wood Medical Clinic Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 950 Matthew Dr Ste D, Waynesboro, MS 39367 Phone: 601-671-2795 Fax: 601-735-4227 |
Wayne General Surgery Clinic Clinic/Center Medicare: Medicare Enrolled Practice Location: 940 Matthew Dr, Suite 5, Waynesboro, MS 39367 Phone: 601-735-7285 |
Wayne General Hospital Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 940 Matthew Dr Ste 8, Waynesboro, MS 39367 Phone: 601-735-7246 Fax: 601-735-7248 |
Wayne General Hospital Family Medicine Medicare: Medicare Enrolled Practice Location: 1325 Azalea Dr, Waynesboro, MS 39367 Phone: 601-671-2825 |
Walley Clinic Pa Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 920 Matthew Dr, Ste A, Waynesboro, MS 39367 Phone: 601-735-2401 Fax: 601-735-5205 |
Mississippi Family Medicine P C Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 940 Matthew Dr, Suite 2, Waynesboro, MS 39367 Phone: 601-671-8555 Fax: 601-671-0777 |
Waynesboro Family Medicine & Obstetrics-nrh Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 951 Matthew Dr, Suite A, Waynesboro, MS 39367 Phone: 601-735-2401 Fax: 601-735-5205 |
News Archive
GlaxoSmithKline and Prosensa today announced that the first patient has commenced treatment in the Phase III clinical study investigating GSK2402968, in ambulant boys with Duchenne Muscular Dystrophy (DMD), who have a dystrophin gene mutation amenable to an exon 51 skip (up to 13% of boys with DMD). Commencement of this study confirms previously announced plans to progress this asset into Phase III.
The Association of Hispanic Healthcare Executives and the National Hispanic Chamber of Commerce on Health today announced the launching of their social media campaign, which will partner Hispanic media, the country's leading Hispanic professional health associations and Hispanic consumers.
Metastatic breast cancer patients who had circulating tumor cells (CTCs) in their blood before or after high-dose chemotherapy (HDCT) followed by autologous stem cell transplantation had poor outcomes, according to researchers from the University of Texas MD Anderson Cancer Center.
A new study could provide the link that scientists have been looking for to confirm that reactivation of a latent herpes virus is a cause of some heart problems.
› Verified 1 days ago